Log In
BCIQ
Print this Print this
 

SCH 900978

  Manage Alerts
Collapse Summary General Information
Company Opko Health Inc.
DescriptionTachykinin receptor (TACR1; NK1R) antagonist
Molecular Target Tachykinin receptor (TACR1) (NK1R)
Mechanism of ActionTachykinin receptor (TACR1) antagonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationCough
Indication DetailsTreat chronic cough
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today